News

Pharmaceutical Technology on MSN11d
FDA approves Biocon Biologics’ bevacizumab biosimilar for cancer
Biocon Biologics has gained approval from the US Food and Drug Administration (FDA) for the intravenous use of Jobevne ...
Drug Store News11d
Biocon Biologics obtains FDA nod for Avastin biosimilar
Biocon Biologics has received the Food and Drug Administration’s green light for Jobevne (bevacizumab-nwgd), a biosimilar ...
EquityBulls11d
Biocon Biologics announces U.S. FDA Approval for Jobevne™, Biosimilar Bevacizumab, Expanding Its Oncology Portfolio
Biocon Biologics Ltd today announced that the U.S. FDA has approved Jobevne™ (bevacizumab-nwgd), a biosimilar Bevacizumab for ...
Medical Dialogues12d
Biocon Biologics gets USFDA nod for cancer drug Jobevne
Bengaluru: Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd, has announced that the U.S. Food and Drug Administration ...
Biocon Biologics Ltd.: Biocon Biologics Announces U.S. FDA Approval for Jobevne, Biosimilar Bevacizumab, Expanding Its Oncology Portfolio
BRIDGEWATER, N.J. and BENGALURU, India, April 10, 2025 /PRNewswire/ -- Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced that the ...